Esperion Therapeutics Inc (ESPR)
3.30
+0.00%
Esperion Therapeutics Inc (ESPR) is currently trading at $3.30. This represents a gain of 0% from the previous session. With a market capitalization of $0.79B, ESPR is a key component of the Health Care sector. Investors looking to trade ESPR should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ESPR commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Esperion Therapeutics Inc (ESPR) shows a bullish trend. Analysts are watching the 0.00 level closely.
Fundamentals
Mkt Cap0.79B
P/E Ratio0.0000
Volume182
60-Day Technical Chart
Advanced Charting
Need more indicators for ESPR? Use the world's #1 platform.
Open ESPR on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $3
| Metric |
ESPR +0.00% |
RXRX +0.00% |
SLDP +0.00% |
ASPN +0.00% |
|---|---|---|---|---|
| Price | $3.30 | $3.53 | $3.54 | $3.56 |
| Mkt Cap | $0.79B | $1.84B | $0.73B | $0.29B |
| - | View → | View → | View → |
Latest Headlines
Generic rival agrees not to copy Esperion cholesterol drugs until 2040
Stock Titan • Feb 17, 2026
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire • Feb 11, 2026
ESPR Stock Drops 17% on Pricing of $75M Common Stock Offering
Yahoo Finance • Oct 9, 2025
Esperion Therapeutics: Still An Attractive Risk/Reward Narrative As The Earnings Clock Ticks Toward Profitability
Seeking Alpha • Nov 10, 2025
$ESPR stock is up 15% today. Here's what we see in our data.
Quiver Quantitative • Nov 25, 2025
● Gemini Agentic AI Analyst Insight for ESPR
Market Education
- October Market Volatility: Why Investors Fear the “Danger Month” Sep 26, 2025
- Blackrock Top Stocks Nov 20, 2023
- What do these rich Traders do - Peek into their day Jul 15, 2023
External Research